Theo Rein

Dr. Theo Rein is a Project Group Leader at the Max Planck Institute of Psychiatry, heading the Project Group Rein within the Department of Genes and Environment. His research integrates molecular psychiatry, stress response mechanisms, and protein biochemistry, with a specialized focus on FKBP51 and autophagy pathways. He investigates molecular underpinnings of depression, neuroimmunology, and the impact of environmental stressors on mental health.

His work spans neuropharmacology, toxicology, and virology, exploring therapeutic targets for psychiatric disorders and viral infections. Research themes include synaptic dysfunction in depression, FKBP51's role in stress adaptation, biomarker development for chemical exposure, and autophagy modulation in antiviral strategies. His publications emphasize interdisciplinary approaches bridging basic science and clinical applications.

Dr. Rein contributes to methodological standards in autophagy research and investigates molecular pathways of major depressive disorder. His collaborations address COVID-19 treatment targets and neuropsychiatric aspects of viral infections. Professional contacts include departmental affiliations and research networks at the Max Planck Institute.